Starfighters Space, Inc.
FJET NYSE Air Transportation, Scheduled Financials FY2024–FY2025
Last close · Oct 23, 2026
$0.75
14.1%What Starfighters Space, Inc. does
No business description yet.
- Legal name
- Starfighters Space, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Apr 15, 2026
- Accession · CIK
- 0001062993-26-002001
0001947016
Revenue and margins
Starfighters Space, Inc. had $0.0M of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$8.4M in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Starfighters Space, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 26.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Starfighters Space, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $8.1M | $19.9M |
| Current ratio | 0.5x | 6.6x |
| Quick ratio | 0.5x | 6.6x |
| Total assets | $10.3M | $28.4M |
| Total liabilities | $16.2M | $3.5M |
| Shareholders' equity | −$5.9M | $24.9M |
| Net debt (− = net cash) | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ |
| Return on assets rose | — | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | ✓ |
| Share count didn't rise | — | ✕ |
| Gross margin rose | — | — |
| Revenue rose relative to assets | — | ✕ |
| F-score | — / 3 | 3 / 7 |
| Accruals ratio | −39.3% | −43.0% |
| Altman Z'' | — | — |
2 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $0.0M | $0.0M |
| Research and development | $0.0M | $1.0M |
| Interest expense | $0.5M | $0.6M |
| Pretax income | −$7.9M | −$16.5M |
| Income tax | $0.0M | $0.0M |
| Net income | −$7.9M | −$16.5M |
| Diluted EPS | −$0.46 | −$0.76 |
| Diluted shares | 0.02B | 0.02B |
| Cash flow | ||
| Cash from operations | −$3.9M | −$8.2M |
| Capital expenditure | $0.0M | $0.2M |
| Free cash flow | −$3.9M | −$8.4M |
| Depreciation and amortization | $0.0M | $0.0M |
| Stock-based compensation | $0.0M | $6.1M |
| Balance sheet | ||
| Cash and short-term investments | $8.1M | $19.9M |
| Current assets | $8.4M | $20.1M |
| Current liabilities | $16.0M | $3.1M |
| Property and equipment, net | $0.1M | $2.4M |
| Total assets | $10.3M | $28.4M |
| Total liabilities | $16.2M | $3.5M |
| Shareholders' equity | −$5.9M | $24.9M |
| Returns | ||
| Return on equity | — | −174.1% |
| Return on assets | −76.8% | −85.5% |
| Return on tangible equity | — | −66.4% |
| Growth | ||
| Share count change | — | 26.0% |
| Financial health | ||
| Current ratio | 0.5x | 6.6x |
| Quick ratio | 0.5x | 6.6x |
| Quality scores | ||
| Piotroski F-score | — | 3.0 |
| Accruals ratio | −39.3% | −43.0% |
Source: SEC EDGAR XBRL filings (CIK 0001947016). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.